These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8903274)

  • 1. Proarrhythmia during drug treatment of supraventricular tachycardia: paradoxical risk of sinus rhythm for sudden death.
    Prystowsky EN
    Am J Cardiol; 1996 Oct; 78(8A):35-41. PubMed ID: 8903274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inpatient versus outpatient initiation of antiarrhythmic drug therapy for patients with supraventricular tachycardia.
    Prystowsky EN
    Clin Cardiol; 1994 Sep; 17(9 Suppl 2):II7-10. PubMed ID: 7882612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The pro-arrhythmic effects of anti-arrhythmia agents].
    Haverkamp W; Wichter T; Chen X; Hördt M; Willems S; Rotman B; Hindricks G; Kottkamp H; Borggrefe M; Breithardt G
    Z Kardiol; 1994; 83 Suppl 5():75-85. PubMed ID: 7846949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
    Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
    Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avoiding drug problems. The safety of drugs for supraventricular tachycardia.
    Reimold SC
    Eur Heart J; 1997 May; 18 Suppl C():C40-4. PubMed ID: 9152674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
    Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group.
    Fish FA; Gillette PC; Benson DW
    J Am Coll Cardiol; 1991 Aug; 18(2):356-65. PubMed ID: 1906902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical types of proarrhythmic response to antiarrhythmic drugs.
    Bigger JT; Sahar DI
    Am J Cardiol; 1987 Apr; 59(11):2E-9E. PubMed ID: 3554950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proarrhythmia: a paradoxic response to antiarrhythmic agents.
    McCollam PL; Parker RB; Beckman KJ; Hariman RJ; Bauman JL
    Pharmacotherapy; 1989; 9(3):144-53. PubMed ID: 2666959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supraventricular tachycardias in neonates and infants: factors associated with fatal or near-fatal outcome.
    Környei L; Szabó A; Róth G; Ferenci T; Kardos A
    Eur J Pediatr; 2021 Aug; 180(8):2669-2676. PubMed ID: 34184119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sudden death of a horse with supraventricular tachycardia following oral administration of flecainide acetate.
    Dembek KA; Hurcombe SD; Schober KE; Toribio RE
    J Vet Emerg Crit Care (San Antonio); 2014; 24(6):759-63. PubMed ID: 25388866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dofetilide: a new class III antiarrhythmic agent.
    Roukoz H; Saliba W
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):9-19. PubMed ID: 17187453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pro-arrhythmia effects of anti-arrhythmia agents--theoretical and clinical aspects].
    Steinbeck G
    Z Kardiol; 1992; 81 Suppl 4():139-43. PubMed ID: 1290290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What have clinical trials taught us about proarrhythmia?
    Skanes AC; Green MS
    Can J Cardiol; 1996 Apr; 12 Suppl B():20B-26B. PubMed ID: 8616725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early and late proarrhythmia from antiarrhythmic drug therapy.
    Morganroth J
    Cardiovasc Drugs Ther; 1992 Feb; 6(1):11-4. PubMed ID: 1533532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Sotalol Still Have a Role in the Management of Arrhythmias?
    Semasinghe Bandaralage SP; Nirthanan S; Niranjan S
    Am J Ther; 2019; 26(1):e161-e169. PubMed ID: 27759583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proarrhythmic effects of antiarrhythmic drugs.
    Ross DL; Cooper MJ; Koo CC; Skinner MP; Davis LM; Richards DA; Uther JB
    Med J Aust; 1990 Jul; 153(1):37-47. PubMed ID: 2199804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proarrhythmia.
    Naccarelli GV; Wolbrette DL; Luck JC
    Med Clin North Am; 2001 Mar; 85(2):503-26, xii. PubMed ID: 11233957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.